RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Net Income Growth TrendStable
Percentile Rank49
Year-over-Year Change
Year-over-year net income growth rate
Latest
0.00%
↑ 100% vs avg
Percentile
P49
Within normal range
Streak
1 qtr
Consecutive declineStable
Average
-19.63%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | 20.21% |
| Q4 2024 | 0.00% |
| Q3 2024 | -67.75% |
| Q2 2024 | 0.00% |
| Q1 2024 | 88.60% |
| Q4 2023 | 0.00% |
| Q3 2023 | -1879.63% |
| Q2 2023 | -98.49% |
| Q1 2023 | 1447.30% |
| Q4 2022 | 89.55% |
| Q3 2022 | -204.85% |
| Q2 2022 | 42.95% |
| Q1 2022 | 15.78% |
| Q4 2021 | -13.96% |
| Q3 2021 | 26.56% |
| Q2 2021 | -27.37% |
| Q1 2021 | 6.03% |
| Q4 2020 | -30.55% |
| Q3 2020 | -16.15% |
| Q2 2020 | 6.47% |
| Q1 2020 | -46.75% |
| Q4 2019 | -18.87% |
| Q3 2019 | 9.84% |
| Q2 2019 | -10.52% |
| Q1 2019 | -28.45% |
| Q4 2018 | 23.79% |
| Q3 2018 | 9.31% |
| Q2 2018 | -11.91% |
| Q1 2018 | 4.59% |
| Q4 2017 | 32.87% |
| Q3 2017 | -40.72% |
| Q2 2017 | -28.23% |
| Q1 2017 | -2.96% |
| Q4 2016 | 6.65% |
| Q3 2016 | -36.51% |
| Q2 2016 | -18.61% |
| Q1 2016 | 15.79% |
| Q4 2015 | -99.27% |
| Q3 2015 | 50.09% |